Key tips for underwriting applicants with GLP1 use Immediately look for: Evidence of the underlying diagnosis (as seen in medical claims, EHR, APS) Whether the GLP-1 is FDA-approved or off-label for that condition Signs of medication adherence (12 months, regular fills) Get cautious when: A GLP1 appears without any supporting clinical context Fills are intermittent or recently initiated Theres no alignment between the medication and expected companion therapies (e.g., no CPAP with sleep apnea) Be confident when: The diagnosis is clear The drug is first line and clinically appropriate Use has been stable long enough to confer benefit Kyle Schimek, PharmD Kyle Schimek is a board-certified pharmacist and Clinical Services Manager at Milliman IntelliScript
To get the best results for your skin, consider these lifestyle adjustments: Diet and Nutrition You can provide your body with the building blocks it needs to make its own glutathione
Mol Cell Toxicol2026 Jan 20
When you take tirzepatide, it binds to receptors in your stomach and intestines, slowing the rate at which food moves from your stomach into your small intestine
For me, as someone who grew up with a lot of weight shaming in my life, I'm somebody who was one of those really the bad case scenarios of diet culture, which is I developed an eating disorder, it really began to destroy my health